SCN3A相关神经发育障碍:癫痫与脑畸形的谱系
该国际多中心研究纳入22例SCN3A致病性变异患者,多数在生后第一年内出现难治性癫痫并伴严重发育迟缓,约79%存在皮质发育畸形。电生理显示多数错义变异为通道功能获得,且所有伴脑畸形的变异均表现为功能获得。
要点
- SCN3A相关神经发育障碍多以婴儿期起病的难治性癫痫和严重发育迟缓为特征。
- 皮质发育畸形是该综合征的特征性表现,见于约79%的受检患者。
- 多数致病性错义变异在电生理上表现为Nav1.3通道功能获得。
核心结论
- SCN3A相关神经发育障碍呈严重程度不一的谱系,通常包括癫痫及严重或极重度发育迟缓/智力障碍。
- 皮质发育畸形是该通道病综合征的特征性表现,见于超过75%的受累个体。
- 发育中神经元通道功能获得可能是疾病发病的重要机制。
研究设计与样本
- 通过国际协作网络招募患者,共纳入22例携带致病性SCN3A变异的患者。
- 在HEK-293T细胞中全细胞电压钳记录,比较野生型与变异型Nav1.3(与β1、β2亚基共表达)的钠通道特性。
主要发现
- 22例患者中16/21(76%)为生后第一年内起病的难治性癫痫,中位起病年龄2周。
- 15/20(75%)存在严重或极重度发育迟缓。
- 15/19(79%)存在皮质发育畸形。
- 致病性变异聚集于域II至域IV的跨膜片段4至6。
- 受检的致病性错义变异中10/11(91%)显示通道功能获得,表现为持续电流增加和/或激活电压依赖性左移。
关键数值与推荐
- 所有与皮质发育畸形相关的变异均表现为通道功能获得。
- 变异p.Ile1468Arg表现为混合效应,兼有功能获得与部分功能丧失。
- 两个变异表现为通道功能丧失。
临床怎么用
- 对婴儿期起病的难治性癫痫伴严重发育迟缓患儿,应考虑SCN3A相关神经发育障碍并行基因检测。
- 发现SCN3A致病性变异时应注意评估皮质发育畸形,影像学检查有助于识别。
- 变异的功能学特征(功能获得为主)可为理解疾病机制提供参考。
局限性
- 研究样本量较小(22例),部分分析存在数据缺失(如部分指标分母小于22)。
- 电生理结果来自HEK-293T异源表达系统,未必完全反映神经元内通道行为。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Pathogenic variants in SCN3A, encoding the voltage-gated sodium channel subunit Nav1.3, cause severe childhood onset epilepsy and malformation of cortical development. Here, we define the spectrum of clinical, genetic, and neuroimaging features of SCN3A-related neurodevelopmental disorder. METHODS: Patients were ascertained via an international collaborative network. We compared sodium channels containing wild-type versus variant Nav1.3 subunits coexpressed with β1 and β2 subunits using whole-cell voltage clamp electrophysiological recordings in a heterologous mammalian system (HEK-293T cells). RESULTS: Of 22 patients with pathogenic SCN3A variants, most had treatment-resistant epilepsy beginning in the first year of life (16/21, 76%; median onset, 2 weeks), with severe or profound developmental delay (15/20, 75%). Many, but not all (15/19, 79%), exhibited malformations of cortical development. Pathogenic variants clustered in transmembrane segments 4 to 6 of domains II to IV. Most pathogenic missense variants tested (10/11, 91%) displayed gain of channel function, with increased persistent current and/or a leftward shift in the voltage dependence of activation, and all variants associated with malformation of cortical development exhibited gain of channel function. One variant (p.Ile1468Arg) exhibited mixed effects, with gain and partial loss of function. Two variants demonstrated loss of channel function. INTERPRETATION: Our study defines SCN3A-related neurodevelopmental disorder along a spectrum of severity, but typically including epilepsy and severe or profound developmental delay/intellectual disability. Malformations of cortical development are a characteristic feature of this unusual channelopathy syndrome, present in >75% of affected individuals. Gain of function at the channel level in developing neurons is likely an important mechanism of disease pathogenesis. ANN NEUROL 2020;88:348-362.
引用
- Zaman T, Helbig KL, Clatot J, et al. SCN3A-Related Neurodevelopmental Disorder: A Spectrum of Epilepsy and Brain Malformation. Ann Neurol. 2020. PMID: 32515017. doi:10.1002/ana.25809
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。